| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Research Abstract |
With the use of a biosensor based on the principle of Forster resonance energy transfer, we isolated imatinib-resistant cells of Ph-positive acute lymphoid leukemia and explored their properties. Twenty-four signaling pathways were found activated in the resistant cells, among which inhibition of the mevalonate pathway was revealed effective in preventing repopulation of such resistant cells. These results thereby indicate that the combined application of statin may serve to cure Ph-positive acute lymphoid leukemia as well as imatinib-resistant chronic myeloid leukemia.
|
